Analysts Predict A Surge In Dyne Therapeutics Inc (NASDAQ: DYN)?

Dyne Therapeutics Inc (NASDAQ:DYN) shares, rose in value on Thursday, May 16, with the stock price down by -2.14% to the previous day’s close as strong demand from buyers drove the stock to $28.75.

Actively observing the price movement in the recent trading, the stock is buoying the session at $29.38. Referring to stock’s 52-week performance, its high was $30.27, and the low was $6.40. On the whole, DYN has fluctuated by 15.83% over the past month.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DYN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of DYN currently trading nearly 11.95% and 8.70% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 64.21, while the 7-day volatility ratio is showing 6.52% which for the 30-day chart, stands at 5.79%. Furthermore, Dyne Therapeutics Inc (DYN)’s beta value is 1.03, and its average true range (ATR) is 1.58.

A comparison of Dyne Therapeutics Inc (DYN) with its peers suggests the former has fared considerably weaker in the market. DYN showed an intraday change of -2.14% in today’s session so far, and over the past year, it grew by 115.36%%.

Data on historical trading for Dyne Therapeutics Inc (NASDAQ:DYN) indicates that the trading volumes over the past 3 months, they’ve averaged 1.23 million. According to company’s latest data on outstanding shares, there are 61.47 million shares outstanding.

Nearly 34.22% of Dyne Therapeutics Inc’s shares belong to company insiders and institutional investors own 82.49% of the company’s shares. The stock has risen by 116.17% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DYN stock heading into the next quarter.

Most Popular